| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
802 |
777 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
188 |
185 |
$10K |
| S8301 |
Infection control supplies, not otherwise specified |
452 |
439 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
193 |
188 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
53 |
52 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
316 |
152 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
471 |
236 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
391 |
379 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
26 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
32 |
31 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
42 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
27 |
26 |
$675.26 |
| 99429 |
|
14 |
13 |
$430.44 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
51 |
39 |
$427.50 |
| 97803 |
|
43 |
42 |
$388.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
30 |
30 |
$312.87 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
12 |
$155.70 |
| 90461 |
|
20 |
14 |
$126.90 |
| 96160 |
|
39 |
39 |
$73.16 |
| 90686 |
|
31 |
31 |
$0.00 |
| 96127 |
|
39 |
39 |
$0.00 |